# IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma

> **NCT00200681** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 493 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT00200681
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-06
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2009-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200681, "IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00200681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*